It’s our honor to introduce the next scientific advisory board member at CarboHyde. Cristin Davidson is the project manager for Support Of Accelerated Research for Niemann-Pick C disease (SOAR-NPC) and a guest researcher at The National Institutes of Health in Bethesda, Maryland.
Her scientific pursuits involve the treatment of rare diseases, as she currently investigates gene therapy and other compounds for NPC disease in small animal models. Cristin was part of an academic/government/family/industry collaborative team that brought 2-hydroxypropyl-beta-#cyclodextrin to a clinical trial for NPC patients. One of her driving motivations is the rapid advancement of disease-modifying therapies for those with limited or no options.
We are over the moon to have you on board, Cristin!
